Loading clinical trials...
Loading clinical trials...
Open-label Early Phase 2 Study With a Single Arm of Interferon Gamma-1b Treatment of Osteopetrosis
Conditions
Interventions
Interferon gamma-1b
Locations
2
United States
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California, United States
University of Minnesota
Minneapolis, Minnesota, United States
Start Date
February 22, 2016
Primary Completion Date
March 11, 2019
Completion Date
April 11, 2019
Last Updated
October 22, 2024
NCT03333200
NCT02065869
NCT04525352
NCT00968864
NCT00775931
Lead Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions